Calvin Sandra bought TVTX

November 4, 2025 · Form 4 insider transaction

Calvin Sandra bought 12,500 shares of Travere Therapeutics, Inc. at $22.40 per share, a transaction worth $280.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.